MedPage Today (6/18, Phend) reported, "Anticoagulation for deep vein thrombosis (DVT) in the calf reduces risk that the clot will propagate and may improve other clinical outcomes as well," according to the research presented at the Society for Vascular Surgery's Vascular annual meeting in Illinois. Among the more than 2,300 studies Randall R. De Martino, MD, of Dartmouth-Hitchcock Medical Center in Lebanon, N.H., and colleagues, "pooled the results of eight studies in adults with ultrasound- or venogram-confirmed calf DVT who were followed for at least one month after treatment with an anticoagulant for at least 30 days or no anticoagulation" and found that "patients who received vitamin K antagonists or heparin had dramatically lower rates of pulmonary embolism and clot propagation compared with those who went without anticoagulants."
POSTED BY STEVEN ALMANY, MD
No comments:
Post a Comment